From: The effect of COVID-19 on prostate cancer testing in Australia
Average 2015–2019 (95%CI) | 2020 | Difference (95%CI; and % of average) | Significance | |
---|---|---|---|---|
PSA tests | 678,082 (660,114 to 704,283) | 657,687 | − 20,395 (− 41,991 to 1200; 97) | P = 0.059 (t = 2.62) |
Prostate MRI | 34,368a | 34,061 | − 307 (†; 99) | N/A† |
Prostate biopsies | 19,573 (18,285 to 20,980) | 20,463 | + 890 (314–2094; 105) | P = 0.109 (t = − 2.05) |